Sitagliptin treatment in patients with type 2 diabetes mellitus after kidney transplant.

Trial Profile

Sitagliptin treatment in patients with type 2 diabetes mellitus after kidney transplant.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Jan 2010

At a glance

  • Drugs Sitagliptin (Primary) ; Sirolimus; Tacrolimus
  • Indications Renal transplant rejection; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 19 Jan 2010 Planned end date changed from 1 Dec 2008 to 1 Mar 2010 as reported by ClinicalTrials.gov.
    • 19 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 10 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top